Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Linzee Mabrey, MD, MsC
Unversity of Washington
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Harborview Medical Center
Seattle, Washington, United States
Linzee Mabrey, MDRecruiting - University of Washington
Seattle, Washington, United States
Eric Morrell, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jun 2026
- Primary completion
- 1 Mar 2029
- Completion
- 1 Jun 2029
- Last update posted
- 29 Jul 2026
- Registered enrollment
- 56
- Registry id
- NCT06513949
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.